ANN REIFF: Open Payments
NPI 1982655601 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 32 payments from 17 companies in 2025. Trend: 2023 $833 · 2024 $1,018 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $81 |
| Amgen Inc. | 3 | $79 |
| Novo Nordisk Inc | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Boston Scientific Corporation | 1 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Exact Sciences Corporation | 3 | $43 |
| CSL Behring | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
Products named: TZIELD, TRELEGY ELLIPTA, REPATHA, Kerendia, WATCHMAN FLX, Ozempic, Veozah, FARXIGA.
Industry payments across AZ — which companies pay providers there.
